•
Mar 31, 2020

Medpace Q1 2020 Earnings Report

Reported first quarter results with revenue increase and net new business awards.

Key Takeaways

Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2020. Revenue increased by 15.0% to $230.9 million compared to the prior-year period. GAAP net income was $29.0 million, or $0.76 per diluted share, versus GAAP net income of $19.2 million, or $0.51 per diluted share, for the first quarter of 2019.

Revenue of $230.9 million increased 15.0% from the prior-year period.

Net new business awards were $246.9 million.

GAAP net income was $29.0 million, or $0.76 per diluted share.

EBITDA was $40.6 million.

Total Revenue
$231M
Previous year: $201M
+15.0%
EPS
$0.76
Previous year: $0.64
+18.8%
Net New Business Awards
$247M
Previous year: $249M
-0.7%
Backlog
$1.3B
Gross Profit
$65.1M
Previous year: $55M
+18.2%
Cash and Equivalents
$134M
Previous year: $30.1M
+344.8%
Free Cash Flow
$43.6M
Previous year: $31.5M
+38.4%
Total Assets
$1.14B
Previous year: $1B
+13.2%

Medpace

Medpace

Forward Guidance

Due to economic uncertainty, the Company is withdrawing previously provided revenue, EBITDA, net income, and net income per diluted share guidance and is not issuing new guidance at this time.